Heron Therapeutics (HRTX) Finished Goods (2016 - 2026)
Heron Therapeutics' (HRTX) quarterly Finished Goods came in at $10.4 million in Q1 2026, up 22.29% YoY from $8.5 million in Q1 2025, and up 50.5% on a QoQ basis from $6.9 million in Q4 2025.
Heron Therapeutics (HRTX) Finished Goods (2016 - 2026) Analysis & Trends
Heron Therapeutics (HRTX) has 11 years of Finished Goods data on file, last reported at $10.4 million in Q1 2026.
- Quarterly Finished Goods rose 22.29% year-over-year to $10.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.4 million (up 22.29% YoY) and the FY2025 annual result came in at $6.9 million, up 10.36% from the prior year.
- Finished Goods rose to $10.4 million in Q1 2026, from $6.9 million in the prior quarter.
- In the past five years, Finished Goods ranged from a high of $22.0 million in Q3 2022 to a low of $6.2 million in Q4 2024.
- A 5-year average of $12.3 million and a median of $10.4 million in 2026 frame the typical range for Finished Goods.
- Annual changes were most pronounced in 2022 — Finished Goods jumped 199.22% — and 2024, when it sank 58.01%.
- Tracing HRTX's Finished Goods over 5 years: stood at $18.7 million in 2022, then tumbled by 47.0% to $9.9 million in 2023, then sank by 37.11% to $6.2 million in 2024, then rose by 10.36% to $6.9 million in 2025, then soared by 50.5% to $10.4 million in 2026.
- The last three Finished Goods figures came in at $10.4 million (Q1 2026), $6.9 million (Q4 2025), and $10.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.72 Bn | 77.73 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.93 Bn | 59.75 Bn | 1.37 Bn |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.97 Bn | 36.87 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.22 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.98 Bn | 9.59 Bn | 668.28 Mn |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - |
| 10 | Heron Therapeutics | 61.10 Mn | 18.43 Mn | 26.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.22 Mn |
| Mar 31, 2026 | 10.36 Mn |
| Dec 31, 2025 | 6.88 Mn |
| Sep 30, 2025 | 10.90 Mn |
| Jun 30, 2025 | 11.00 Mn |
| Mar 31, 2025 | 8.47 Mn |
| Dec 31, 2024 | 6.24 Mn |
| Sep 30, 2024 | 6.78 Mn |
| Jun 30, 2024 | 7.22 Mn |
| Mar 31, 2024 | 8.11 Mn |
| Dec 31, 2023 | 9.92 Mn |
| Sep 30, 2023 | 9.98 Mn |
| Jun 30, 2023 | 17.19 Mn |
| Mar 31, 2023 | 17.74 Mn |
| Dec 31, 2022 | 18.71 Mn |
| Sep 30, 2022 | 22.03 Mn |
| Jun 30, 2022 | 19.37 Mn |
| Mar 31, 2022 | 17.52 Mn |
| Dec 31, 2021 | 6.25 Mn |
| Sep 30, 2021 | 8.98 Mn |